What is Merck & Co.'s debt instrument, fair value disclosure?

Merck & Co. (MRK) reported debt instrument, fair value disclosure of $44.70B in Q1 2026.

What does debt instrument, fair value disclosure mean?

The current market price to buy back or pay off the company's debt.

Discontinued — last reported Q3 '20

Debt Instrument, Fair Value Disclosure

Merck & Co. Debt Instrument, Fair Value Disclosure decreased by 2.0% to $44.70B in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryLeverage

SignalContext dependent

VolatilityModerate

First reportedQ4 2017

Last reportedQ3 2020

How to read this metric

If the fair value is significantly lower than the carrying amount, it may indicate an opportunity to repurchase debt at a discount or reflect rising market interest rates.

Detailed definition

This represents the estimated fair market value of the company's total debt obligations, which may differ from the carry...

Peer comparison

Publicly traded companies with significant bond issuances are required to disclose this to show the market's current valuation of their credit risk.

Metric ID: other_debt_instrument_fair_value

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$45.60B	$44.70B
QoQ Change	—	-2.0%

Range$44.70B – $45.60B

Debt Instrument, Fair Value Disclosure at Other Companies

West Pharmaceutical ServicesWST View metric

Frequently Asked Questions

What is Merck & Co.'s debt instrument, fair value disclosure?: Merck & Co. (MRK) reported debt instrument, fair value disclosure of $44.70B in Q1 2026.
What does debt instrument, fair value disclosure mean?: The current market price to buy back or pay off the company's debt.